ADCC Mediated B-Cell dEpletion and BAFF-R Blockade (AMBER)
Study description
VAY736 dose testing; VAY736 efficacy and safety testing.
Pathology
Autoimmune Hepatitis
Study type
Clinical trial
Status
Active
Study start date
2017
Study completion date
2022
Funder Type
Industry funded study
Investigator
Dr.ssa med. Benedetta TERZIROLI BERETTA-PICCOLI
Recruitment
Recruiting
For information, please contact the Foundation